Polarisqb

The Quantum-Aided Drug Design platform uses commercially available quantum annealing technology to explore a 10^30 chemical space, optimize objectives at once, and provide explainable results.

The blog for PolarisQB, the first company in the world to develop a drug discovery platform for a quantum computer, Quantum-Aided Drug Design (QuADD).

The page compares the pros and cons of Quantum-Aided Drug Design (QuADD) and AI for drug discovery.

The page compares the pros and cons of Quantum-Aided Drug Design (QuADD) and traditional CADD for drug discovery.

The page features news and developments from PolarisQB, including industry insights on quantum-aided drug design.

The PolarisQB team combines expertise in physics (quantum computing), biology (genetics) and chemistry (molecular drugs) to revolutionize drug design.

Quantum-aided drug design explores chemical spaces beyond conventional computing and optimizes drug candidates.

The page invites inquiries about partnerships, services, and the Quantum-Aided Drug Design (QuADD) platform for drug discovery, agricultural, and other molecular research projects.

The page describes PolarisQB's Quantum-Aided Drug Design (QuADD) as a drug discovery engine developed for a quantum computer. It says companies in biotech, pharmaceutical, agricultural, and other molecular research sectors can use the platform to find molecular leads.

The privacy policy describes how Polaris Quantum Biotech, Inc. and its corporate affiliates collect, use, share, and transfer information provided to PolarisQB.

Polaris Quantum Biotech, Inc. maintains this website and linked PolarisQB websites, collectively defined as the Site, and the information and materials on them.